309 related articles for article (PubMed ID: 11911253)
1. Matrix metalloproteinases (MMPs) in breast cancer cell lines of different tumorigenicity.
Bachmeier BE; Nerlich AG; Lichtinghagen R; Sommerhoff CP
Anticancer Res; 2001; 21(6A):3821-8. PubMed ID: 11911253
[TBL] [Abstract][Full Text] [Related]
2. Enhanced expression and activation of major matrix metalloproteinases in distinct topographic areas of invasive breast carcinomas.
Bachmeier BE; Rohrbach H; De Waal J; Jochum M; Nerlich AG
Int J Oncol; 2005 May; 26(5):1203-7. PubMed ID: 15809710
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical pattern of cytokeratins and MMPs in human keratinocyte cell lines of different biological behaviour.
Bachmeier BE; Nerlich AG
Int J Oncol; 2002 Mar; 20(3):495-9. PubMed ID: 11836560
[TBL] [Abstract][Full Text] [Related]
4. Cell density-dependent regulation of matrix metalloproteinase and TIMP expression in differently tumorigenic breast cancer cell lines.
Bachmeier BE; Albini A; Vené R; Benelli R; Noonan D; Weigert C; Weiler C; Lichtinghagen R; Jochum M; Nerlich AG
Exp Cell Res; 2005 Apr; 305(1):83-98. PubMed ID: 15777790
[TBL] [Abstract][Full Text] [Related]
5. Human keratinocyte cell lines differ in the expression of the collagenolytic matrix metalloproteinases-1,-8, and -13 and of TIMP-1.
Bachmeier BE; Nerlich AG; Boukamp P; Lichtinghagen R; Tschesche H; Fritz H; Fink E
Biol Chem; 2000; 381(5-6):509-16. PubMed ID: 10937883
[TBL] [Abstract][Full Text] [Related]
6. Oxygen-mediated regulation of gelatinase and tissue inhibitor of metalloproteinases-1 expression by invasive cells.
Canning MT; Postovit LM; Clarke SH; Graham CH
Exp Cell Res; 2001 Jul; 267(1):88-94. PubMed ID: 11412041
[TBL] [Abstract][Full Text] [Related]
7. Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells.
Jones JL; Shaw JA; Pringle JH; Walker RA
J Pathol; 2003 Dec; 201(4):562-72. PubMed ID: 14648659
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases-2,-3,-7,-9 and-10, but not MMP-11, are differentially expressed in normal, benign tumorigenic and malignant human keratinocyte cell lines.
Bachmeier BE; Boukamp P; Lichtinghagen R; Fusenig NE; Fink E
Biol Chem; 2000; 381(5-6):497-507. PubMed ID: 10937882
[TBL] [Abstract][Full Text] [Related]
9. Additional MDA-MB-231 breast cancer cell matrix metalloproteinases promote invasiveness.
Hegedüs L; Cho H; Xie X; Eliceiri GL
J Cell Physiol; 2008 Aug; 216(2):480-5. PubMed ID: 18286480
[TBL] [Abstract][Full Text] [Related]
10. A molecular role for lysyl oxidase in breast cancer invasion.
Kirschmann DA; Seftor EA; Fong SF; Nieva DR; Sullivan CM; Edwards EM; Sommer P; Csiszar K; Hendrix MJ
Cancer Res; 2002 Aug; 62(15):4478-83. PubMed ID: 12154058
[TBL] [Abstract][Full Text] [Related]
11. Production of matrix metalloproteinases by cultured bovine theca and granulosa cells.
Smith MF; Gutierrez CG; Ricke WA; Armstrong DG; Webb R
Reproduction; 2005 Jan; 129(1):75-87. PubMed ID: 15615900
[TBL] [Abstract][Full Text] [Related]
12. Modulation of monocyte matrix metalloproteinase-2 by breast adenocarcinoma cells.
Szabo KA; Singh G
Breast Cancer Res; 2005; 7(5):R661-8. PubMed ID: 16168111
[TBL] [Abstract][Full Text] [Related]
13. Characterization of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in prostate cancer cell lines.
Daja MM; Niu X; Zhao Z; Brown JM; Russell PJ
Prostate Cancer Prostatic Dis; 2003; 6(1):15-26. PubMed ID: 12664060
[TBL] [Abstract][Full Text] [Related]
14. Effects of Shugansanjie Tang on matrix metalloproteinases 1, 3 and 9 and telomerase reverse transcriptase expression in human breast cells in vitro.
Loo WT; Chen JP; Chow LW; Chou JW
Biomed Pharmacother; 2007 Oct; 61(9):601-5. PubMed ID: 17913446
[TBL] [Abstract][Full Text] [Related]
15. Metalloproteinases and their inhibitors: influence on tumor invasiveness and metastasis formation in head and neck squamous cell carcinomas.
Görögh T; Beier UH; Bäumken J; Meyer JE; Hoffmann M; Gottschlich S; Maune S
Head Neck; 2006 Jan; 28(1):31-9. PubMed ID: 16265652
[TBL] [Abstract][Full Text] [Related]
16. Tissue distribution of major matrix metalloproteinases and their transcripts in human breast carcinomas.
Lebeau A; Nerlich AG; Sauer U; Lichtinghagen R; Löhrs U
Anticancer Res; 1999; 19(5B):4257-64. PubMed ID: 10628384
[TBL] [Abstract][Full Text] [Related]
17. Production of matrix metalloproteinases in specific subpopulations of human-patient breast cancer invading in three dimensional culture system.
Loo WT; Cheung MN; Chow LW
Life Sci; 2004 Dec; 76(7):743-52. PubMed ID: 15581906
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of resistin-13-peptide on the proliferation, adhesion, and invasion of MDA-MB-231 in human breast carcinoma cells.
Pan B; Zhao MH; Chen Z; Lu L; Wang Y; Shi DW; Han PZ
Endocr Relat Cancer; 2007 Dec; 14(4):1063-71. PubMed ID: 18045957
[TBL] [Abstract][Full Text] [Related]
19. [6]-Gingerol inhibits metastasis of MDA-MB-231 human breast cancer cells.
Lee HS; Seo EY; Kang NE; Kim WK
J Nutr Biochem; 2008 May; 19(5):313-9. PubMed ID: 17683926
[TBL] [Abstract][Full Text] [Related]
20. Prominent expression of metalloproteinases in early stages of ovarian tumorigenesis.
Cai KQ; Yang WL; Capo-Chichi CD; Vanderveer L; Wu H; Godwin AK; Xu XX
Mol Carcinog; 2007 Feb; 46(2):130-43. PubMed ID: 17131304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
